{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:39:19Z","timestamp":1787017159938,"version":"build-2736575974"},"reference-count":43,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T00:00:00Z","timestamp":1636243200000},"content-version":"unspecified","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M007588\/1"],"award-info":[{"award-number":["MR\/M007588\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,10,21]]},"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Liver cirrhosis is a growing global healthcare challenge. Cirrhosis is characterised by severe liver fibrosis, organ dysfunction and complications related to portal hypertension. There are no licensed antifibrotic or proregenerative medicines and liver transplantation is a scarce resource. Hepatic macrophages can promote both liver fibrogenesis and fibrosis regression. The safety and feasibility of peripheral infusion of ex vivo matured autologous monocyte-derived macrophages in patients with compensated cirrhosis has been demonstrated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The efficacy of autologous macrophage therapy, compared with standard medical care, will be investigated in a cohort of adult patients with compensated cirrhosis in a multicentre, open-label, parallel-group, phase 2, randomised controlled trial. The primary outcome is the change in Model for End-Stage Liver Disease score at 90 days. The trial will provide the first high-quality examination of the efficacy of autologous macrophage therapy in improving liver function, non-invasive fibrosis markers and other clinical outcomes in patients with compensated cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial will be conducted according to the ethical principles of the Declaration of Helsinki 2013 and has been approved by Scotland A Research Ethics Committee (reference 15\/SS\/0121), National Health Service Lothian Research and Development department and the Medicine and Health Care Regulatory Agency-UK. Final results will be presented in peer-reviewed journals and at relevant conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"ISRCTN10368050\">ISRCTN10368050<\/jats:ext-link>\n                      and EudraCT; reference 2015-000963-15\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-053190","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T11:51:05Z","timestamp":1636372265000},"page":"e053190","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":45,"title":["Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8368-1478","authenticated-orcid":false,"given":"Paul Noel","family":"Brennan","sequence":"first","affiliation":[{"name":"Centre for Regenerative Medicine, The University of Edinburgh Medical School, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"MacMillan","sequence":"additional","affiliation":[{"name":"Centre for Regenerative Medicine, The University of Edinburgh Medical School, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Manship","sequence":"additional","affiliation":[{"name":"CLDD, NHS Lothian, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Moroni","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, NHS Grampian, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Glover","sequence":"additional","affiliation":[{"name":"Scottish National Blood Transfusion Service, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Graham","sequence":"additional","affiliation":[{"name":"Deanery of Clinical Sciences, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Semple","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, The University of Edinburgh Deanery of Clinical Sciences, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Morris","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, The University of Edinburgh Deanery of Clinical Sciences, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair R","family":"Fraser","sequence":"additional","affiliation":[{"name":"Tissues, Cells and Advanced Therapeutics, SNBTS, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Pass","sequence":"additional","affiliation":[{"name":"Tissues, Cells and Advanced Therapeutics, SNBTS, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W A","family":"McGowan","sequence":"additional","affiliation":[{"name":"Tissues, Cells and Advanced Therapeutics, SNBTS, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L","family":"Turner","sequence":"additional","affiliation":[{"name":"Tissues, Cells and Advanced Therapeutics, SNBTS, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Lachlan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, NHS Greater Glasgow and Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F","family":"Dillon","sequence":"additional","affiliation":[{"name":"Liver Group, University of Dundee Division of Cardiovascular and Diabetes Medicine, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D M","family":"Campbell","sequence":"additional","affiliation":[{"name":"Tissues, Cells and Advanced Therapeutics, SNBTS, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Andrew","family":"Fallowfield","sequence":"additional","affiliation":[{"name":"Queen\"s Medical Research Institute, University of Edinburgh MRC Centre for Inflammation Research, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J","family":"Forbes","sequence":"additional","affiliation":[{"name":"Centre for Regenerative Medicine, The University of Edinburgh Deanery of Clinical Sciences, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"2025121514172675000_11.11.e053190.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.014"},{"key":"2025121514172675000_11.11.e053190.2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"2025121514172675000_11.11.e053190.3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121514172675000_11.11.e053190.4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cld.480","article-title":"Overall health-related quality of life in patients with end-stage liver disease","volume":"6","author":"Younossi","year":"2015","journal-title":"Clin Liver Dis"},{"key":"2025121514172675000_11.11.e053190.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-006-9131-y"},{"key":"2025121514172675000_11.11.e053190.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.013"},{"key":"2025121514172675000_11.11.e053190.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.09.027"},{"key":"2025121514172675000_11.11.e053190.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.048"},{"key":"2025121514172675000_11.11.e053190.9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14728214.2021.1918099","article-title":"Emerging synthetic drugs for the treatment of liver cirrhosis","volume":"26","author":"Fallowfield","year":"2021","journal-title":"Expert Opin Emerg Drugs"},{"key":"2025121514172675000_11.11.e053190.10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/lt.24462","article-title":"Liver transplantation in the United Kingdom","volume":"22","author":"Neuberger","year":"2016","journal-title":"Liver Transpl"},{"key":"2025121514172675000_11.11.e053190.11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/gut.47.3.441","article-title":"Effect on outcome of the lengthening waiting list for liver transplantation","volume":"47","author":"Ransford","year":"2000","journal-title":"Gut"},{"key":"2025121514172675000_11.11.e053190.12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4254\/wjh.v7.i10.1355","article-title":"Review on immunosuppression in liver transplantation","volume":"7","author":"Moini","year":"2015","journal-title":"World J Hepatol"},{"key":"2025121514172675000_11.11.e053190.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.040"},{"key":"2025121514172675000_11.11.e053190.14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jhep.2020.09.014","article-title":"Cell therapy for advanced liver diseases: repair or rebuild","volume":"74","author":"Dwyer","year":"2021","journal-title":"J Hepatol"},{"key":"2025121514172675000_11.11.e053190.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053719"},{"key":"2025121514172675000_11.11.e053190.16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (realistic): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"Newsome","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121514172675000_11.11.e053190.17","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-5-S1-S27"},{"key":"2025121514172675000_11.11.e053190.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119964109"},{"key":"2025121514172675000_11.11.e053190.19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3653"},{"key":"2025121514172675000_11.11.e053190.20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24315"},{"key":"2025121514172675000_11.11.e053190.21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1302168110"},{"key":"2025121514172675000_11.11.e053190.22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jcyt.2015.07.016","article-title":"Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study","volume":"17","author":"Moore","year":"2015","journal-title":"Cytotherapy"},{"key":"2025121514172675000_11.11.e053190.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.031"},{"key":"2025121514172675000_11.11.e053190.24","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41591-019-0599-8","article-title":"Safety profile of autologous macrophage therapy for liver cirrhosis","volume":"25","author":"Moroni","year":"2019","journal-title":"Nat Med"},{"key":"2025121514172675000_11.11.e053190.25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jcyt.2017.05.009","article-title":"Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: a novel cellular therapeutic for liver cirrhosis","volume":"19","author":"Fraser","year":"2017","journal-title":"Cytotherapy"},{"key":"2025121514172675000_11.11.e053190.26","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.transproceed.2008.05.072","article-title":"Model for end-stage liver disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?","volume":"40","author":"Cuomo","year":"2008","journal-title":"Transplant Proc"},{"key":"2025121514172675000_11.11.e053190.27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21563"},{"key":"2025121514172675000_11.11.e053190.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.08.052"},{"key":"2025121514172675000_11.11.e053190.29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/00365521.2014.996590","article-title":"Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis","volume":"50","author":"Leeming","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"2025121514172675000_11.11.e053190.30","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12820"},{"key":"2025121514172675000_11.11.e053190.31","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.111302"},{"key":"2025121514172675000_11.11.e053190.32","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.295"},{"key":"2025121514172675000_11.11.e053190.33","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3748\/wjg.15.3288","article-title":"Psychometrics of the chronic liver disease questionnaire for southern Chinese patients with chronic hepatitis B virus infection","volume":"15","author":"Lam","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2025121514172675000_11.11.e053190.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9708-x"},{"key":"2025121514172675000_11.11.e053190.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2015-000069"},{"key":"2025121514172675000_11.11.e053190.36","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318225db4d"},{"key":"2025121514172675000_11.11.e053190.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.10.009"},{"key":"2025121514172675000_11.11.e053190.38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ab.2017.01.018","article-title":"In-vivo\n                  31\n               P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism","volume":"529","author":"Valkovic","year":"2017","journal-title":"Anal Biochem"},{"key":"2025121514172675000_11.11.e053190.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2025121514172675000_11.11.e053190.40","doi-asserted-by":"publisher","DOI":"10.1186\/scrt535"},{"key":"2025121514172675000_11.11.e053190.41","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/liv.12228","article-title":"Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis","volume":"33","author":"Mohamadnejad","year":"2013","journal-title":"Liver Int"},{"key":"2025121514172675000_11.11.e053190.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007700"},{"key":"2025121514172675000_11.11.e053190.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02424.x"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-053190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:17:34Z","timestamp":1765837054000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-053190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,8]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/bmjopen-2021-053190"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-053190","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}